Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the captopril study

American Journal of Kidney Diseases

Volumn 34, Issue 2, 1999, Pages 308-314

  Wilmer, W A ^a   Hebert, L A ^a   Lewis, E J ^a   Rohde, R D ^a   Whittier, F ^a   Cattran, D ^a   Levey, A S ^a   Lewis, J B ^a   Spitalewitz, S ^a   Blumenthal, S ^a   Bain, R P ^a  

^a Means Hall   (United States)

Author keywords

Angiotensin converting enzyme (ACE) inhibitors; Captopril Study; Diabetic nephropathy; Nephrotic syndrome

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTIC SYNDROME; RANDOMIZED CONTROLLED TRIAL;

EID: 0032780640     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70360-4     Document Type: Article

References (36)

1. EJ Lewis LG Hunsicker RP Bain RD Rohde for the Collaborative Study Group The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1993 1456 1462
2. LA Hebert RP Bain D Verme D Cattran FC Whittier N Tolchin RD Rohde EJ Lewis Remission of nephrotic-range proteinuria in type I diabetes. Collaborative Study Group Kidney Int 46 1994 1688 1693
3. SM Austin JS Lieberman LD Newton M Mejia WA Peters BD Myers Slope of serial glomerular filtration rate and the progression of diabetic glomerular disease J Am Soc Nephrol 3 1993 1358 1370
4. MH Gault D Fernandez Stable renal function in insulin-dependent diabetes mellitus 10 years after nephrotic-range proteinuria Nephron 72 1996 86 92
5. D McGregor RR Bailey Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor Nephron 76 1997 270 275
6. C Burton KP Harris The role of proteinuria in the progression of chronic renal failure Am J Kidney Dis 27 1996 765 775
7. P Ruggenenti A Perna L Mosconi M Matalone R Pisoni F Gaspari G Remuzzi Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The “Gruppo Italiano di Studi Epidemiologici in Nefrologia” (GISEN) Kidney Int 63 1997 S54 S57 (suppl)
8. G Remuzzi P Ruggenenti A Benigni Understanding the nature of renal disease progression Kidney Int 51 1997 2 15
9. AA Eddy Molecular insights into renal interstitial fibrosis J Am Soc Nephrol 7 1996 2495 2508
10. AA Eddy Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions J Am Soc Nephrol 5 1994 1273 1287
11. AA Eddy Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephrotic syndrome Am J Physiol 266 1994 F884 F893
12. A Benigni C Zoja G Remuzzi The renal toxicity of sustained glomerular protein traffic Lab Invest 73 1995 461 468
13. JA Breyer RP Bain JK Evans NS Nahman Jr EJ Lewis M Cooper J McGill T Berl Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy. The Collaborative Study Group Kidney Int 50 1996 1651 1658
14. JC Peterson S Adler JM Burkart T Greene LA Hebert LG Hunsicker AJ King S Klahr SG Massry JL Seifter Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study Ann Intern Med 123 1995 754 762
15. P Ruggenenti G Remuzzi The renoprotective action of angiotensin-converting enzyme inhibitors in diabetes Exp Nephrol 4 suppl 1 1996 S53 S60
16. I Giatras J Lau AS Levey Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: A meta-analysis of randomized trials. Angiotensin-Converting Enzyme Inhibition and Progressive Renal Disease Study Group Ann Intern Med 127 1997 337 345
17. AJ Apperloo D de Zeeuw PE de Jong Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with nondiabetic renal disease Kidney Int 45 1994 S174 S178 (suppl)
18. HH Parving L Tarnow P Rossing Renal protection in diabetes: An emerging role for calcium antagonists J Hypertens 14 1996 S21 S25 (suppl)
19. HH Parving Impact of blood pressure and antihypertensive treatment on incipient and overt nephropathy, retinopathy, and endothelial permeability in diabetes mellitus Diabetes Care 14 1991 260 269
20. BK Demarie GL Bakris Effects of different calcium antagonists on proteinuria associated with diabetes mellitus Ann Intern Med 113 1990 987 988
21. R Slataper N Vicknair R Sadler GL Bakris Comparative effects of different antihypertensive treatments on progression of diabetic renal disease Arch Intern Med 153 1993 973 980
22. S Mizuiri H Yoshikawa M Tanegashima M Miyagi M Kobayashi K Sakai I Hayashi A Aikawa T Ohara A Hasegawa Renal ACE immunohistochemical localization in NIDDM patients with nephropathy Am J Kidney Dis 31 1998 301 307
23. L Tarnow F Cambien P Rossing FS Nielsen BV Hansen L Lecerf O Poirier S Danilov HH Parving Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients Diabetes 44 1995 489 494
24. L Tarnow F Cambien P Rossing FS Nielsen BV Hansen S Ricard O Poirier HH Parving Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy Diabetes 45 1996 367 369
25. HH Parving P Jacobsen L Tarnow P Rossing L Lecerf O Poirier F Cambien Effect of deletion polymorphism of angiotensin-converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin-converting enzyme: Observational follow-up study BMJ 313 1996 591 594
26. BW Jeffers RO Estacio MV Raynolds RW Schrier Angiotensin-converting enzyme gene polymorphism in non–insulin-dependent diabetes mellitus and its relationship with diabetic nephropathy Kidney Int 52 1997 473 477
27. TA Chowdhury PH Dyer S Kumar SC Gough SP Gibson BR Rowe PR Smith MJ Dronsfield SM Marshall P Mackin JD Dean PJ Morris S Davies DB Dunger AJ Boulton AH Barnett SC Bain Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus Diabet Med 14 1997 837 840
28. P Jacobsen K Rossing P Rossing L Tarnow C Mallet O Poirier F Cambien HH Parving Angiotensin-converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy Kidney Int 53 1998 1002 1006
29. PW Anderson YS Do WA Hsueh Angiotensin II causes mesangial cell hypertrophy Hypertension 21 1993 29 35
30. S Kagami WA Border DE Miller NA Noble Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells J Clin Invest 93 1994 2431 2437
31. G Wolf E Mueller RA Stahl FN Ziyadeh Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta J Clin Invest 92 1993 1366 1372
32. NS Nahman Jr KL Rothe ME Falkenhain KM Frazer LE Dacio JD Madia KL Leonhart JC Kronenberger DA Stauch Angiotensin II induction of fibronectin biosynthesis in cultured human mesangial cells: Association with CREB transcription factor activation J Lab Clin Med 127 1996 599 611
33. FN Ziyadeh MP Cohen Effects of glycated albumin on mesangial cells: Evidence for a role in diabetic nephropathy Mol Cell Biochem 125 1993 19 25
34. CW Yang H Vlassara EP Peten CJ He GE Striker LJ Striker Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease Proc Natl Acad Sci U S A 91 1994 9436 9440
35. MP Cohen FN Ziyadeh Role of amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy J Am Soc Nephrol 7 1996 183 190
36. DR McCance DG Dyer JA Dunn KE Bailie SR Thorpe JW Baynes TJ Lyons Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus J Clin Invest 91 1993 2470 2478